{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:08:34Z","timestamp":1790010514478,"version":"4.0.1"},"reference-count":29,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Thyroglobulin autoantibodies (TgAbs) affect thyroglobulin immunometric assays (TgIMAs), causing falsely low results. Conversely, heterophilic antibodies (HAs) may cause falsely elevated results. Thyroglobulin (Tg) measurements by mass spectrometry (MS) resist antibody interference. The most effective use of TgIMA\/TgMS in the evaluation of Tg remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of this work was to study the usefulness of TgMS vs TgIMA in the presence of Tg measurement interference by HA and TgAb.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In 163 thyroid cancer patients, Tg was postoperatively measured by TgIMA and TgMS. When TgIMA was elevated and TgMS undetectable, HA was assessed by serial dilution and pretreatment with HA blocking reagent. TgIMA and TgMS were compared in TgAb-positive patients with well-characterized clinical status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>6 out of 45 cases with TgIMA &amp;gt;1\u2005ng\/mL had undetectable TgMS. HA interference was confirmed by serial dilution and HA blocking reagent addition. In TgAb-positive cases, TgIMA and TgMS were highly correlated (R2 = 0.86). In patients with structural disease and TgAb, TgIMA and TgMS were detectable in 6\/19 patients, and 9\/19 cases, respectively. The TgMS concentration range in the 3 discrepant cases ranged from 0.5 to 2.0\u2005ng\/mL. Hence, the presence of TgAb was associated with inappropriately reduced Tg concentrations with both TgIMA and TgMS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>HA cause falsely elevated TgIMA with undetectable TgMS with significant frequency. TgMS can be used to rule out HA interference. Albeit resistant to TgAb in vitro, TgMS detects little Tg in patients with TgAb and structural disease. Hence, TgAb may reduce Tg concentrations in vivo. The implication is that no assay design may be able to overcome this problem. TgMS may not detect structural disease in TgAb-positive patients.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jendso\/bvac169","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T05:20:02Z","timestamp":1667366402000},"source":"Crossref","is-referenced-by-count":14,"title":["Thyroglobulin Assay Interferences: Clinical Usefulness of Mass-Spectrometry Methods"],"prefix":"10.1210","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0356-2749","authenticated-orcid":false,"given":"Giuseppe","family":"Barbesino","sequence":"first","affiliation":[{"name":"Thyroid Unit, Massachusetts General Hospital-Harvard Medical School , Boston, MA 02114 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Algeciras-Schimnich","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, MN 55092 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Bornhorst","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, MN 55092 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"11","key":"2022113011100485800_bvac169-B1","first-page":"3877","article-title":"A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer","volume":"84","author":"Haugen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"2022113011100485800_bvac169-B2","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.1983.03340170078037","article-title":"The value of serum thyroglobulin measurement in clinical practice","volume":"250","author":"Refetoff","year":"1983","journal-title":"JAMA"},{"issue":"April 15","key":"2022113011100485800_bvac169-B3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cca.2014.10.035","article-title":"Thyroglobulin in differentiated thyroid cancer","volume":"444","author":"Evans","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"8","key":"2022113011100485800_bvac169-B4","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2002-021925","article-title":"Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma","volume":"88","author":"Pacini","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2022113011100485800_bvac169-B5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.eprac.2020.10.011","article-title":"False positives in thyroglobulin determinations due to the presence of heterophile antibodies: an underrecognized and consequential clinical problem","volume":"27","author":"Barbesino","year":"2021","journal-title":"Endocr Pract"},{"issue":"5","key":"2022113011100485800_bvac169-B6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","article-title":"Heterophilic antibody interference in immunometric assays","volume":"27","author":"Bolstad","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"2022113011100485800_bvac169-B7","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1515\/CCLM.2009.230","article-title":"Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma","volume":"47","author":"Giovanella","year":"2009","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"2022113011100485800_bvac169-B8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1210\/er.2018-00119","article-title":"Interferences with thyroid function immunoassays: clinical implications and detection algorithm","volume":"39","author":"Favresse","year":"2018","journal-title":"Endocr Rev"},{"issue":"7","key":"2022113011100485800_bvac169-B9","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1373\/clinchem.2014.224816","article-title":"Usefulness of a thyroglobulin liquid chromatography-tandem mass spectrometry assay for evaluation of suspected heterophile interference","volume":"60","author":"Netzel","year":"2014","journal-title":"Clin Chem"},{"issue":"3","key":"2022113011100485800_bvac169-B10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/acta.0.1190373","article-title":"Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome","volume":"119","author":"Pacini","year":"1988","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"4","key":"2022113011100485800_bvac169-B11","first-page":"1121","article-title":"Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma","volume":"83","author":"Spencer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2022113011100485800_bvac169-B12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jcem-49-4-557","article-title":"Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera","volume":"49","author":"Bayer","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2022113011100485800_bvac169-B13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0009-8981(82)90181-4","article-title":"Evaluation of a solid-phase immunoradiometric assay (IRMA) for serum thyroglobulin: effect of anti-thyroglobulin autoantibody","volume":"123","author":"Mariotti","year":"1982","journal-title":"Clin Chim Acta"},{"issue":"2","key":"2022113011100485800_bvac169-B14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/jcem.80.2.7852506","article-title":"Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?","volume":"80","author":"Mariotti","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2022113011100485800_bvac169-B15","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1210\/jc.2005-0671","article-title":"Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas","volume":"90","author":"Spencer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2022113011100485800_bvac169-B16","doi-asserted-by":"crossref","first-page":"E1074","DOI":"10.1210\/jc.2015-1967","article-title":"Thyroglobulin (Tg) testing revisited: Tg assays, TgAb assays, and correlation of results with clinical outcomes","volume":"100","author":"Netzel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2022113011100485800_bvac169-B17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/jcem-47-1-126","article-title":"Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies","volume":"47","author":"Schneider","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2022113011100485800_bvac169-B18","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/jc.2014-1203","article-title":"Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications","volume":"99","author":"Spencer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2022113011100485800_bvac169-B19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/jalm\/jfab083","article-title":"A novel thyroglobulin immunoassay using the specimen-pretreatment process improves the accuracy of thyroglobulin measurements in anti-thyroglobulin positive specimens","volume":"6","author":"Kitamura","year":"2021","journal-title":"J Appl Lab Med"},{"issue":"8","key":"2022113011100485800_bvac169-B20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2310\/JIM.0b013e318276deb4","article-title":"A novel mass spectrometry-based assay for the accurate measurement of thyroglobulin from patient samples containing antithyroglobulin autoantibodies","volume":"60","author":"Clarke","year":"2012","journal-title":"J Investig Med"},{"issue":"1","key":"2022113011100485800_bvac169-B21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/thy.2016.0210","article-title":"Thyroglobulin liquid chromatography-tandem mass spectrometry has a low sensitivity for detecting structural disease in patients with antithyroglobulin antibodies","volume":"27","author":"Azmat","year":"2017","journal-title":"Thyroid"},{"issue":"11","key":"2022113011100485800_bvac169-B22","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1373\/clinchem.2008.109652","article-title":"Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry","volume":"54","author":"Hoofnagle","year":"2008","journal-title":"Clin Chem"},{"issue":"2","key":"2022113011100485800_bvac169-B23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ecl.2008.02.008","article-title":"Follow up approaches in thyroid cancer: a risk adapted paradigm","volume":"37","author":"Tuttle","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"2022113011100485800_bvac169-B24","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2007-2357","article-title":"Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer","volume":"93","author":"Kloos","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2022113011100485800_bvac169-B25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clon.2010.05.005","article-title":"Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan","volume":"22","author":"Chao","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"2022113011100485800_bvac169-B26","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1210\/jc.2003-030122","article-title":"Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays","volume":"88","author":"Preissner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2022113011100485800_bvac169-B27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1186\/s13104-017-3050-6","article-title":"Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS\/MS measurements in an urban hospital","volume":"10","author":"Wheeler","year":"2017","journal-title":"BMC Res Notes"},{"issue":"6","key":"2022113011100485800_bvac169-B28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4049\/jimmunol.98.6.1105","article-title":"The behavior of autologous thyroglobulin in the circulation of rabbits immunized with either heterologous or altered homologous thyroglobulin","volume":"98","author":"Weigle","year":"1967","journal-title":"J Immunol"},{"issue":"1","key":"2022113011100485800_bvac169-B29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2265.1980.tb03129.x","article-title":"Sequential changes in serum thyroglobulin (Tg) and its autoantibodies (TgAb) following subtotal thyroidectomy of patients with preoperatively detectable TgAb","volume":"12","author":"Feldt-Rasmussen","year":"1980","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvac169\/46747803\/bvac169.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/7\/1\/bvac169\/47448269\/bvac169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/7\/1\/bvac169\/47448269\/bvac169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T23:23:10Z","timestamp":1678490590000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvac169\/6793713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,11,17]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvac169","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,11,2]]},"article-number":"bvac169"}}